Incannex Healthcare Limited

Incannex Healthcare Limited - ROEverified

IXHL

Price:

$3.56

Market Cap:

$42.59M

Incannex Healthcare Limited is an Australian company dedicated to the research, development, and commercialization of medicinal cannabinoid products. The firm offers pharmaceutical-grade cannabinoid compounds under its proprietary Incannex brand. Its product pipeline includes several key assets: IHL-42X: This compound is currently undergoing Phase II clinical evaluation for the treatment of obstructive sleep apnea (OSA). Incannex partners with The Alfred Hospital and Novotech on this specific clinical program. IHL-216A: Designed to address traumatic brain injury (TBI). Furthermore, the Monash Trauma Group, part of Monash University's Department of Neuroscience, is conducting a study on IHL-2...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2022-03-02

Stock Exchange

NASDAQ

Ticker

IXHL

The ROE as of June 2026 (TTM) for Incannex Healthcare Limited (IXHL) is -122.57%

According to Incannex Healthcare Limited’s latest financial reports and current stock price. The company's current ROE is -122.57%. This represents a change of 75.27% compared to the average of -69.93% of the last 4 quarters.

Incannex Healthcare Limited (IXHL) Historical ROE (quarterly & annually)

How has IXHL ROE performed in the past?

The mean historical ROE of Incannex Healthcare Limited over the last ten years is 1.27%. The current -122.57% ROE has changed -109.65% with respect to the historical average. Over the past ten years (40 quarters), IXHL's ROE was at its highest in in the June 2017 quarter at 570.25%. The ROE was at its lowest in in the December 2016 quarter at -549.91%.

Quarterly (TTM)
Annual

Average

1.27%

Median

-87.02%

Minimum

-350.18%

Maximum

12.25%

Incannex Healthcare Limited (IXHL) ROE by Quarter and Year

Discovering the peaks and valleys of Incannex Healthcare Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 11.82%

Maximum Annual ROE = 12.25%

Minimum Annual Increase = -122.84%

Minimum Annual ROE = -350.18%

Quarterly (TTM)
Annual
YearROEChange
2025-350.18%112.79%
2024-164.56%-29.79%
2023-234.39%466.15%
2022-41.40%-68.79%
2021-132.65%-10.65%
2020-148.45%-122.84%
2019650.03%-14.84%
2018763.31%-93.77%
201712.25%11.82%
2016102.80%-119.22%

Incannex Healthcare Limited (IXHL) Average ROE

How has IXHL ROE performed in the past?

The current ROE of Incannex Healthcare Limited (IXHL) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

-249.71%

5-year avg

-184.63%

10-year avg

1.27%

Incannex Healthcare Limited (IXHL) ROE vs. Peers

How is IXHL’s ROE compared to its peers?

Incannex Healthcare Limited’s ROE is greater than Zhengye Biotechnology Holding Limited (-26.15%), less than Sharps Technology, Inc. (11.97%), greater than Agenus Inc. (-23.05%), greater than Lucid Diagnostics Inc. (-370.21%), less than Scilex Holding Company (190.13%), greater than Cognition Therapeutics, Inc. (-72.68%), greater than Seer, Inc. (-26.58%), greater than China SXT Pharmaceuticals, Inc. (-14.68%), less than Opus Genetics, Inc. (6.07%), greater than Turn Therapeutics Inc. (-116.83%),

Build a custom stock screener for Incannex Healthcare Limited (IXHL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Incannex Healthcare Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Incannex Healthcare Limited (IXHL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Incannex Healthcare Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Incannex Healthcare Limited's ROE?

How is the ROE calculated for Incannex Healthcare Limited (IXHL)?

What is the highest ROE for Incannex Healthcare Limited (IXHL)?

What is the 3-year average ROE for Incannex Healthcare Limited (IXHL)?

What is the 5-year average ROE for Incannex Healthcare Limited (IXHL)?

How does the current ROE for Incannex Healthcare Limited (IXHL) compare to its historical average?